Cadrenal Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.356; its P/E ratio is -1.24; Cadrenal Therapeutics, Inc. is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	$ -220.09K	-	-	-
EBIT	$ -1.15M	$ -11.38M	$ -1.00M	$ 5.17M	-
EBITDA	$ -1.15M	$ -11.38M	-	$ 5.16M	-
Net Income Common Stockholders	$ -1.14M	$ -11.38M	$ -1.00M	$ 5.17M	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 8.40M	$ 9.11M	$ 3.23M	$ 4.03M	$ 32.59K
Total Assets	$ 8.52M	$ 9.31M	$ 3.56M	$ 4.48M	$ 778.17K
Total Debt	$ 21.35K	$ 27.22K	$ 32.86K	$ 38.33K	$ 640.71K
Net Debt	$ -8.38M	$ -9.08M	$ -3.20M	$ -3.99M	$ 608.12K
Total Liabilities	$ 826.88K	$ 565.80K	$ 383.10K	$ 416.80K	$ 6.33M
Stockholders Equity	$ 7.69M	$ 8.75M	$ 3.18M	$ 4.07M	$ -5.55M
Cash Flow	-
Free Cash Flow	$ -694.45K	$ -627.78K	-	$ -1.41M	-
Operating Cash Flow	$ -694.45K	$ -627.78K	-	$ -1.41M	-
Investing Cash Flow	-	$ -1.00	-	-	-
Financing Cash Flow	$ -12.50K	$ 6.51M	-	$ 5.41M	-

Currency in USD

Cadrenal Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Cadrenal Therapeutics, Inc. Debt to Assets

Balance Sheet >

Cadrenal Therapeutics, Inc. Cash Flow

Cash Flow >

Cadrenal Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing